BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1718842)

  • 1. A neutralizing monoclonal antibody binds to an epitope near the amino terminus of murine granulocyte-macrophage colony-stimulating factor.
    Meropol NJ; Kreider BL; Lee VM; Kaushansky K; Prystowsky MB
    Hybridoma; 1991 Aug; 10(4):433-47. PubMed ID: 1718842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptides.
    Greenfield RS; Braslawsky GR; Kadow KF; Spitalny GL; Chace D; Bull CO; Bursuker I
    J Immunol; 1993 Jun; 150(12):5241-51. PubMed ID: 8515057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunodominant epitope in a functional domain near the N-terminus of human granulocyte-macrophage colony-stimulating factor identified by cross-reaction of synthetic peptides with neutralizing anti-protein and anti-peptide antibodies.
    Beffy P; Rovero P; Di Bartolo V; Laricchia Robbio L; Dané A; Pegoraro S; Bertolero F; Revoltella RP
    Hybridoma; 1994 Dec; 13(6):457-68. PubMed ID: 7737670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions.
    Von Feldt JM; Monfardini C; Kieber-Emmons T; Voet D; Weiner DB; Williams WV
    Immunol Res; 1994; 13(2-3):96-109. PubMed ID: 7539825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro.
    Dempsey PJ; Layton JE; Duhrsen U; Nicola NA; Cebon J; Burgess AW; Morstyn G
    Hybridoma; 1990 Dec; 9(6):545-58. PubMed ID: 1706312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells.
    Chan CH; Blazar BR; Eide CR; Kreitman RJ; Vallera DA
    Blood; 1995 Oct; 86(7):2732-40. PubMed ID: 7670112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize the receptor binding domain of the molecule.
    Brown CB; Hart CE; Curtis DM; Bailey MC; Kaushansky K
    J Immunol; 1990 Mar; 144(6):2184-9. PubMed ID: 1690239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization.
    Sebollela A; Cagliari TC; Limaverde GS; Chapeaurouge A; Sorgine MH; Coelho-Sampaio T; Ramos CH; Ferreira ST
    J Biol Chem; 2005 Sep; 280(36):31949-56. PubMed ID: 16027123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of monoclonal antibody- and receptor-binding domains on human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) using a surface plasmon resonance-based biosensor.
    Laricchia-Robbio L; Liedberg B; Platou-Vikinge T; Rovero P; Beffy P; Revoltella RP
    Hybridoma; 1996 Oct; 15(5):343-50. PubMed ID: 8913783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.
    Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK
    Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functionally distinct domains of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies.
    Kanakura Y; Cannistra SA; Brown CB; Nakamura M; Seelig GF; Prosise WW; Hawkins JC; Kaushansky K; Griffin JD
    Blood; 1991 Mar; 77(5):1033-43. PubMed ID: 1704802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular structure and granulocyte/macrophage colony-stimulating factor activity.
    Von Feldt JM; Kieber-Emmons T; Weiner DB; Ugen KE; Williams WV
    DNA Cell Biol; 1992 Apr; 11(3):183-91. PubMed ID: 1373625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody.
    Eylenstein R; Weinfurtner D; Härtle S; Strohner R; Böttcher J; Augustin M; Ostendorp R; Steidl S
    MAbs; 2016; 8(1):176-86. PubMed ID: 26406987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activation.
    Shanafelt AB; Kastelein RA
    J Biol Chem; 1992 Dec; 267(35):25466-72. PubMed ID: 1460041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the carboxyl terminus of human granulocyte-macrophage colony-stimulating factor in the binding of ligand to the alpha-subunit of the high affinity receptor.
    Seelig GF; Prosise WW; Scheffler JE
    J Biol Chem; 1994 Feb; 269(8):5548-53. PubMed ID: 8119889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant antibodies in bioactive peptide design.
    Monfardini C; Kieber-Emmons T; VonFeldt JM; O'Malley B; Rosenbaum H; Godillot AP; Kaushansky K; Brown CB; Voet D; McCallus DE
    J Biol Chem; 1995 Mar; 270(12):6628-38. PubMed ID: 7896802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of a mouse granulocyte macrophage-colony-stimulating factor receptor antagonist.
    Altmann SW; Kastelein RA
    J Biol Chem; 1995 Feb; 270(5):2233-40. PubMed ID: 7836455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF): identification of a binding site for a neutralizing antibody.
    Nice E; Dempsey P; Layton J; Morstyn G; Cui DF; Simpson R; Fabri L; Burgess A
    Growth Factors; 1990; 3(2):159-69. PubMed ID: 1698402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.
    Oggero M; Frank R; Etcheverrigaray M; Kratje R
    Mol Divers; 2004; 8(3):257-69. PubMed ID: 15384419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design, analysis, and potential utility of GM-CSF antagonists.
    Monfardini C; Kieber-Emmons T; VonFeldt JM; Godillot AP; Voet D; Weiner DB; Williams WV
    Proc Assoc Am Physicians; 1996 Nov; 108(6):420-31. PubMed ID: 8956365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.